Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Fareed

Showing results (211-220 of 393) with videos related to

Pageof 40
Sort By:
International Angiology : a Journal of the International Union of Angiology|April 16, 2016
Effect of erythropoietin stimulating agents on vascular endothelial growth factor levels in patients with end stage renal diseaseJennifer L Saluk, Vinoid K Bansal, Debra A Hoppensteadt, et al.
International Angiology : a Journal of the International Union of Angiology|June 10, 2017
Biomarker profiling of plasma samples utilizing RANDOX biochip array technologyJennifer Saluk, Debra Hoppensteadt, Danyel Syed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2018
Angiopoietin 2 Levels in the Risk Stratification and Mortality Outcome Prediction of Sepsis-Associated CoagulopathyStephen Statz, Giselle Sabal, Amanda Walborn, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 11, 2018
Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded EnoxaparinWalter Jeske, Ahmed Kouta, Rick Duff, et al.
Thrombosis Journal|February 24, 2026
Multifactorial thrombotic risk in Evans syndrome: a case report and review of the literatureHande Nur Erolmez, Semih Eker, Fakiha Siddiqui, et al.
Research and Practice in Thrombosis and Haemostasis|June 15, 2026
Thromboinflammation and hemostatic activation drive early mortality risk in pulmonary embolismFakiha Siddiqui, Alfonso Tafur, Amir Darki, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 29, 2020
Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet AlfaFakiha Siddiqui, Darko Antic, Alfonso Tafur, et al.
Psychiatry Research|January 28, 2020
Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome predictionMonica Feliz R Castillo, Arielle Cohen, David Edberg, et al.
Thrombosis Journal|April 20, 2022
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patientsVladimir Otasevic, Biljana Mihaljevic, Natasa Milic, et al.
International Angiology : a Journal of the International Union of Angiology|March 19, 2021
Do we have a unified consensus on antithrombotic management of PAD?Pavel Poredos, Pier L Antignani, Ales Blinc, et al.
Pageof 40

Showing results (211-220 of 393) with videos related to

Sort By:
Pageof 40
International Angiology : a Journal of the International Union of Angiology|April 16, 2016
Effect of erythropoietin stimulating agents on vascular endothelial growth factor levels in patients with end stage renal diseaseJennifer L Saluk, Vinoid K Bansal, Debra A Hoppensteadt, et al.
International Angiology : a Journal of the International Union of Angiology|June 10, 2017
Biomarker profiling of plasma samples utilizing RANDOX biochip array technologyJennifer Saluk, Debra Hoppensteadt, Danyel Syed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2018
Angiopoietin 2 Levels in the Risk Stratification and Mortality Outcome Prediction of Sepsis-Associated CoagulopathyStephen Statz, Giselle Sabal, Amanda Walborn, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 11, 2018
Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded EnoxaparinWalter Jeske, Ahmed Kouta, Rick Duff, et al.
Thrombosis Journal|February 24, 2026
Multifactorial thrombotic risk in Evans syndrome: a case report and review of the literatureHande Nur Erolmez, Semih Eker, Fakiha Siddiqui, et al.
Research and Practice in Thrombosis and Haemostasis|June 15, 2026
Thromboinflammation and hemostatic activation drive early mortality risk in pulmonary embolismFakiha Siddiqui, Alfonso Tafur, Amir Darki, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 29, 2020
Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet AlfaFakiha Siddiqui, Darko Antic, Alfonso Tafur, et al.
Psychiatry Research|January 28, 2020
Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome predictionMonica Feliz R Castillo, Arielle Cohen, David Edberg, et al.
Thrombosis Journal|April 20, 2022
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patientsVladimir Otasevic, Biljana Mihaljevic, Natasa Milic, et al.
International Angiology : a Journal of the International Union of Angiology|March 19, 2021
Do we have a unified consensus on antithrombotic management of PAD?Pavel Poredos, Pier L Antignani, Ales Blinc, et al.
Pageof 40